Sonoma Pharmaceuticals, Inc.
No enriched coverage for $SNOA in the last 7 days.
No SEC Form 4 filings for $SNOA in the last 30 days.
Sonoma Pharmaceuticals has closed a public unit offering, raising approximately $3.5 million in net proceeds after expenses. The offering included units of common stock or pre-funded warrants, complemented by common stock purchase warrants, with each unit priced at $1.35. The funds are earmarked for general corporate purposes and working capital.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
U.S. stocks traded mostly lower this morning, with the Dow Jones index falling more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.32% to 44,775.87 while the NASDAQ fell 0.09% to 21,693.26. The S&P 500 also fell, dropping, 0.17% to 6,455.42.
